首页> 外文期刊>Antioxidants and redox signalling >Deferoxamine lowers tissue damage after 80% exchange transfusion with polymerized hemoglobin.
【24h】

Deferoxamine lowers tissue damage after 80% exchange transfusion with polymerized hemoglobin.

机译:用聚合血红蛋白进行80%交换输血后,去铁胺可降低组织损伤。

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Hemoglobin (Hb) solutions have been proposed as potential substitutes for erythrocytes to maintain oxygen-carrying capacity in situations in which blood is not available. This study investigated systemic and microvascular hemodynamics as well as tissue oxygenation and viability after an 80% exchange transfusion with an oxygen-carrying blood substitute based on polymerized bovine hemoglobin (PBH). Studies were carried in unanesthetized hamsters prepared with a window-chamber model for microcirculation evaluation. Heme iron-mediated injury to the tissue was analyzed by using deferoxamine (an iron chelator), which reduces free iron toxicity. Exchange transfusion led to a significant decrease in hematocrit (Hct) and an increase in plasma Hb, in addition to a significant decrease of arteriolar and venular diameters, flow velocity, and, therefore, microvascular blood flow. Capillary perfusion was severely compromised after exchange, but tissue pO2 increased above baseline, and oxygen extraction was reduced. Apoptotic and necrotic cells increased significantly after the exchange; however, this effect was only partially due to the toxicity of free iron. Iron therapy decreased the microvascular and oxygenation changes but did not fully reverse the adverse effects. Assessment of tissue viability after exchange suggests that chelation treatment in cases of large exchange transfusions with acellular Hb could be potentially beneficial.
机译:已经提出了血红蛋白(Hb)溶液作为红细胞的潜在替代品,以在没有血液的情况下保持携氧能力。这项研究调查了基于聚合牛血红蛋白(PBH)的载氧血液替代品进行80%交换输血后的全身和微血管血流动力学以及组织氧合和活力。在未麻醉的仓鼠中进行研究,该仓鼠用窗室模型制备以进行微循环评估。血红素铁介导的组织损伤通过使用去铁胺(一种铁螯合剂)进行分析,这降低了游离铁的毒性。交换输血导致血细胞比容(Hct)显着降低,血浆Hb升高,此外小动脉和小静脉直径,流速以及微血管血流量也显着降低。更换后毛细血管灌注严重受损,但组织中pO2升高至基线以上,氧气提取减少。交换后凋亡和坏死细胞明显增加;但是,这种作用仅部分归因于游离铁的毒性。铁疗法减少了微血管和氧合的变化,但并未完全逆转不良反应。交换后组织活力的评估表明,在进行大量无细胞Hb交换输血的情况下进行螯合治疗可能具有潜在的益处。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号